Regeneron Genetics Center, Tarrytown, NY, 10591, USA.
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 10591, USA.
Commun Biol. 2022 Jun 3;5(1):540. doi: 10.1038/s42003-022-03408-7.
To better understand the genetics of hearing loss, we performed a genome-wide association meta-analysis with 125,749 cases and 469,497 controls across five cohorts. We identified 53/c loci affecting hearing loss risk, including common coding variants in COL9A3 and TMPRSS3. Through exome sequencing of 108,415 cases and 329,581 controls, we observed rare coding associations with 11 Mendelian hearing loss genes, including additive effects in known hearing loss genes GJB2 (Gly12fs; odds ratio [OR] = 1.21, P = 4.2 × 10) and SLC26A5 (gene burden; OR = 1.96, P = 2.8 × 10). We also identified hearing loss associations with rare coding variants in FSCN2 (OR = 1.14, P = 1.9 × 10) and KLHDC7B (OR = 2.14, P = 5.2 × 10). Our results suggest a shared etiology between Mendelian and common hearing loss in adults. This work illustrates the potential of large-scale exome sequencing to elucidate the genetic architecture of common disorders where both common and rare variation contribute to risk.
为了更好地了解听力损失的遗传学,我们在五个队列中对 125749 例病例和 469497 例对照进行了全基因组关联荟萃分析。我们确定了影响听力损失风险的 53/c 个位点,包括 COL9A3 和 TMPRSS3 中的常见编码变异。通过对 108415 例病例和 329581 例对照进行外显子组测序,我们观察到 11 个常染色体隐性遗传性听力损失基因与罕见编码相关,包括已知听力损失基因 GJB2(Gly12fs;优势比 [OR] = 1.21,P = 4.2×10)和 SLC26A5(基因负担;OR = 1.96,P = 2.8×10)中的加性效应。我们还发现了 FSCN2(OR = 1.14,P = 1.9×10)和 KLHDC7B(OR = 2.14,P = 5.2×10)中罕见编码变异与听力损失的相关性。我们的研究结果表明成人常染色体隐性遗传和常见听力损失之间存在共同的病因。这项工作说明了大规模外显子组测序阐明常见疾病遗传结构的潜力,其中常见和罕见变异均有助于风险。